Neuer Auftrag Institute

Neuer Auftrag Institute
The Neuer Auftrag Institute was a German multinational company, who operated in 12 countries, making genetic and chemical research, with medicines were destined to hospitals and laboratories. And because of the sprouting of many companies of the same branch, the INA finished their activities in the year of 1998.
Neuer Auftrag Institute's History
They was established in the years 70 in Leipzig, Germany, for Dierk Adalricus,
and in little time the Institute Neuer Auftrag had initiated the activities
in England, United States, Denmark, Austria, Russia and France, following later for
Turkey and Egypt. In 1981, they arrived until China, Japan and
Australia, and in 1988, it arrived at Brazil. The Institute Neuer Auftrag always worked
in right-hander support with governments and laboratories. With the aid of other companies
the Institute Neuer Auftrag developed remedies and vaccines that total had been directed to
the hospitals and research of governmental bodies. In the start of the decade of 90,
competitors had started to appear and a competition for chosen teams brought new employees
the company and the company kept its as place. In 1998, she locked up its activities for
financial reasons and of competition. Its founder and president, Dierk Adalricus, also
disappeared together with its company.
Profitability and Financial Performance
In 1989, the Institute Neuer Auftrag had a profit of 11,8 billion dollar, a fall of 17%
in relation to its record in 1988. A significant increase in the profit of the company happens
in 1995, 21,7 billion dollar. The increase in the production of vaccines and medicines and thus,
its bigger use for laboratories and hospitals and the increase of the prices was one of the
responsible factors for this improvement.

Main Menu

See Also

Main Menu